Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term adalimumab continuation in RA
NCT00233571Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2000
- Primary completion
- Jun 2006
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Jun 2000; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00233571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00233571.